Abstract
Transformation of a normal cell into a cancer cell requires sequential accumulation of several genetic changes that affect various collaborating signaling cascades mainly involved in cell proliferation, survival and development [46]. To develop novel specific therapeutic compounds for cancer treatment, identification of these cancer causing genes, and subsequently the oncogenic pathways in which these genes act, is of utmost importance. Although a great deal of insight in the cellular mechanisms that lead to cancer has been obtained, many key players are still unidentified. Retroviral insertional mutagenesis (IM) screens provide one of the most efficient tools to identify genes involved in tumorigenesis and from there the specific oncogenic pathways involved.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acha-Orbea, H., & MacDonald, H. R. (1995). Superantigens of mouse mammary tumor virus. Annual Reviews of Immunology, 13, 459–486.
Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A. A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003). Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Research, 63, 4920–4926.
Androutsellis-Theotokis, A., Leker, R. R., Soldner, F., Hoeppner, D. J., Ravin, R., Poser, S. W., et al. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature, 442, 823–826.
Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., et al. (2006). Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proceedings of the National Academy of Sciences USA, 103, 3799–3804.
Ball, J. K., Diggelmann, H., Dekaban, G. A., Grossi, G. F., Semmler, R., Waight, P. A., et al. (1988). Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. Journal of Virology, 62, 2985–2993.
Bannert, N., & Kurth, R. (2004). Retroelements and the human genome: New perspectives on an old relation. Proceedings of the National Academy of Sciences USA, 101(Suppl 2), 14572–14579.
Bhadra, S., Lozano, M. M., & Dudley, J. P. (2005). Conversion of mouse mammary tumor virus to a lymphomagenic virus. Journal of Virology, 79, 12592–12596.
Binnerts, M., Kim, K., Bright, J., Patel, S., Tran, K., Zhou, M., et al. (2007). R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proceedings of the National Academy of Sciences USA, 104, 14700–14705.
Bittner, J. J. (1936). Some possible effects of nursing on the mammary gland tumor incidence in mice. Science, 84, 162.
Broussard, D. R., Lozano, M. M., & Dudley, J. P. (2004). Rorgamma (Rorc) is a common integration site in type B leukemogenic virus-induced T-cell lymphomas. Journal of Virology, 78, 4943–4946.
Brown, P. O. (1997). Integration. In J. M. Coffin, S. H. Hughes, & H. E. Varmus (Eds.), Retroviruses (pp. 161–203). Cold Spring Harbor Laboratory Press (NY), USA.
Callahan, R., & Smith, G. H. (2000). MMTV-induced mammary tumorigenesis: Gene discovery, progression to malignancy and cellular pathways. Oncogene, 19, 992–1001.
Callahan, R., & Smith, G. H. (2008). Common integration sites for MMTV in viral induced mouse mammary tumors. Journal of Mammary Gland Biology and Neoplasia, 13, 309–321.
Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., et al. (2000). The mammary pathology of genetically engineered mice: The consensus report and recommendations from the annapolis meeting. Oncogene, 19, 968–988.
Cato, A. C., Miksicek, R., Schutz, G., Arnemann, J., & Beato, M. (1986). The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO Journal, 5, 2237–2240.
Chalepakis, G., Arnemann, J., Slater, E., Bruller, H. J., Gross, B., & Beato, M. (1988). Differential gene activation by glucocorticoids and progestins through the hormone regulatory element of mouse mammary tumor virus. Cell, 53, 371–382.
Choi, Y., Kappler, J. W., & Marrack, P. (1991). A superantigen encoded in the open reading frame of the 3’ long terminal repeat of mouse mammary tumour virus. Nature, 350, 203–207.
Chu, E. Y., Hens, J., Andl, T., Kairo, A., Yamaguchi, T. P., Brisken, C., et al. (2004). Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development, 131, 4819–4829.
Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell, 127, 469–480.
Collier, L. S., Carlson, C. M., Ravimohan, S., Dupuy, A. J., & Largaespada, D. A. (2005). Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature, 436, 272–276.
Courreges, M. C., Burzyn, D., Nepomnaschy, I., Piazzon, I., & Ross, S. R. (2007). Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. Journal of Virology, 81, 3769–3777.
de Ridder, J., Uren, A., Kool, J., Reinders, M., & Wessels, L. (2006). Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLoS Computational Biology, 2, e166.
DeOme, K. B., Faulkin, L. J., Jr., Bern, H. A., & Blair, P. B. (1959). Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Research, 19, 515–520.
Dickson, C., & Peters, G. (1987). Potential oncogene product related to growth factors. Nature, 326, 833.
Dievart, A., Beaulieu, N., & Jolicoeur, P. (1999). Involvement of Notch1 in the development of mouse mammary tumors. Oncogene, 18, 5973–5981.
Dillon, R. L., White, D. E., & Muller, W. J. (2007). The phosphatidyl inositol 3-kinase signaling network: Implications for human breast cancer. Oncogene, 26, 1338–1345.
Dontu, G., Jackson, K. W., McNicholas, E., Kawamura, M. J., Abdallah, W. M., & Wicha, M. S. (2004). Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Research, 6, R605–R615.
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D., Thompson, D., Ballinger, D. G., et al. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087–1093.
Entin-Meer, M., Avidan, O., & Hizi, A. (2003). The mature reverse transcriptase molecules in virions of mouse mammary tumor virus possess protease-derived sequences. Virology, 310, 157–162.
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine and Growth Factor Reviews, 16, 139–149.
Fantozzi, A., & Christofori, G. (2006). Mouse models of breast cancer metastasis. Breast Cancer Research, 8, 212.
Faschinger, A., Rouault, F., Sollner, J., Lukas, A., Salmons, B., Gunzburg, W. H., et al. (2008). Mouse mammary tumor virus integration site selection in human and mouse genomes. Journal of Virology, 82, 1360–1367.
Fioravanti, L., Cappelletti, V., Coradini, D., Miodini, P., Borsani, G., Daidone, M. G., et al. (1997). Int-2 oncogene amplification and prognosis in node-negative breast carcinoma. International Journal of Cancer, 74, 620–624.
Gallahan, D., & Callahan, R. (1997). The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene, 14, 1883–1890.
Gallahan, D., & Callahan, R. (1987). Mammary tumorigenesis in feral mice: Identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. Journal of Virology, 61, 66–74.
Gallahan, D., Jhappan, C., Robinson, G., Hennighausen, L., Sharp, R., Kordon, E., et al. (1996). Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Research, 56, 1775–1785.
Gattelli, A., Zimberlin, M. N., Meiss, R. P., Castilla, L. H., & Kordon, E. C. (2006). Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines. Journal of Virology, 80, 11409–11415.
Goedert, J. J., Rabkin, C. S., & Ross, S. R. (2006). Prevalence of serologic reactivity against four strains of mouse mammary tumour virus among US women with breast cancer. British Journal of Cancer, 94, 548–551.
Golovkina, T. V., Dudley, J. P., & Ross, S. R. (1998). B and T cells are required for mouse mammary tumor virus spread within the mammary gland. Journal of Immunology, 161, 2375–2382.
Gotoh, N. (2009). Control of stemness by fibroblast growth factor signaling in stem cells and cancer stem cells. Current Stem Cell Research and Therapy, 4, 9–15.
Grimm, S. L., & Nordeen, S. K. (1998). Mouse mammary tumor virus sequences responsible for activating cellular oncogenes. Journal of Virology, 72, 9428–9435.
Grimm, S. L., & Nordeen, S. K. (1999). A composite enhancer element directing tissue-specific expression of mouse mammary tumor virus requires both ubiquitous and tissue-restricted factors. Journal of Biological Chemistry, 274, 12790–12796.
Grose, R., & Dickson, C. (2005). Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Reviews, 16, 179–186.
Gunther, E. J., Moody, S. E., Belka, G. K., Hahn, K. T., Innocent, N., Dugan, K. D., et al. (2003). Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes and Development, 17, 488–501.
Gunzburg, W. H., & Salmons, B. (1992). Factors controlling the expression of mouse mammary tumour virus. Biochemical Journal, 283(Pt 3), 625–632.
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57–70.
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., et al. (1998). Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351, 1393–1396.
Held, W., Shakhov, A. N., Izui, S., Waanders, G. A., Scarpellino, L., MacDonald, H. R., et al. (1993a). Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. Journal of Experimental Medicine, 177, 359–366.
Held, W., Waanders, G. A., Shakhov, A. N., Scarpellino, L., Acha-Orbea, H., & MacDonald, H. R. (1993b). Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell, 74, 529–540.
Henrard, D., & Ross, S. R. (1988). Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland. Journal of Virology, 62, 3046–3049.
Hilkens, J. (2006). Recent translational research: Oncogene discovery by insertional mutagenesis gets a new boost. Breast Cancer Research, 8, 102.
Hilkens, J., van der, Z. B., Buijs, F., Kroezen, V., Bleumink, N., & Hilgers, J. (1983). Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16. Journal of Virology, 45, 140–147.
Hollmann, C. A., Kittrell, F. S., Medina, D., & Butel, J. S. (2001). Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Oncogene, 20, 7645–7657.
Howe, L. R., & Brown, A. M. (2004). Wnt signaling and breast cancer. Cancer Biology and Therapy., 3, 36–41.
Hsu, C. L., Fabritius, C., & Dudley, J. (1988). Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. Journal of Virology, 62, 4644–4652.
Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., et al. (2007). A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nature Genetics, 39, 870–874.
Hynes, N., van Ooyen, A. J., Kennedy, N., Herrlich, P., Ponta, H., & Groner, B. (1983). Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proceedings of the National Academy of Sciences of the USA, 80, 3637–3641.
Imai, S., Morimoto, J., Tsubura, Y., Iwai, Y., Okumoto, M., Takamori, Y., et al. (1983). Tissue and organ distribution of mammary tumor virus antigens in low and high mammary cancer strain mice. European Journal of Cancer and Clinical Oncology, 19, 1011–1019.
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., et al. (2008). Cancer statistics. CA Cancer Journal of Clinicians, 58, 71–96.
Jessen, J. R. (2009). Noncanonical Wnt signaling in tumor progression and metastasis. Zebrafish, 6, 21–28.
Jhappan, C., Gallahan, D., Stahle, C., Chu, E., Smith, G. H., Merlino, G., et al. (1992). Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes and Development, 6, 345–355.
Jonkers, J., & Berns, A. (1996). Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochimica et Biophysica Acta, 1287, 29–57.
Jonkers, J., & Berns, A. (2002). Conditional mouse models of sporadic cancer. Nature Reviews Cancer, 2, 251–265.
Kapoun, A. M., & Shackleford, G. M. (1997). Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice. Oncogene, 14, 2985–2989.
Kazanskaya, O., Glinka, A., Barco Barrantes, I., Stannek, P., Niehrs, C., & Wu, W. (2004). R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. Developmental Cell, 7, 525–534.
Kikuchi, A., Yamamoto, H., & Sato, A. (2009). Selective activation mechanisms of Wnt signaling pathways. Trends in Cell Biology, 19, 119–129.
Kim, K. A., Kakitani, M., Zhao, J., Oshima, T., Tang, T., Binnerts, M., et al. (2005). Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science, 309, 1256–1259.
Kim, K. A., Wagle, M., Tran, K., Zhan, X., Dixon, M. A., Liu, S., et al. (2008). R-Spondin family members regulate the Wnt pathway by a common mechanism. Molecular Biology of the Cell, 19, 2588–2596.
Klarmann, G. J., Decker, A., & Farrar, W. L. (2008). Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics, 3, 59–63.
Klinakis, A., Szabolcs, M., Politi, K., Kiaris, H., Artavanis-Tsakonas, S., & Efstratiadis, A. (2006). Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proceedings of the National Academy Of Sciences of theUSA, 103, 9262–9267.
Kopan, R., & Ilagan, M. X. (2009). The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell, 137, 216–233.
Koppe, B., Menendez-Arias, L., & Oroszlan, S. (1994). Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity. Journal of Virology, 68, 2313–2319.
Kordon, E. C., & Smith, G. H. (1998). An entire functional mammary gland may comprise the progeny from a single cell. Development, 125, 1921–1930.
Kwan, H., Pecenka, V., Tsukamoto, A., Parslow, T. G., Guzman, R., Lin, T. P., et al. (1992). Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Molecular and Cellular Biology, 12, 147–154.
Lane, T. F., & Leder, P. (1997). Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Oncogene, 15, 2133–2144.
Lavan, B. E., Fantin, V. R., Chang, E. T., Lane, W. S., Keller, S. R., & Lienhard, G. E. (1997). A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. Journal of Biological Chemistry, 272, 21403–21407.
Lee, F. S., Lane, T. F., Kuo, A., Shackleford, G. M., & Leder, P. (1995). Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proceedings of the National Academy of Sciences of the USA, 92, 2268–2272.
Li, Y., Podsypanina, K., Liu, X., Crane, A., Tan, L. K., Parsons, R., et al. (2001). Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Molecular Biology, 2, 2.
Lin, S. Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., et al. (2000). Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of the USA, 97, 4262–4266.
Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N. S., Jackson, K. W., et al. (2006). Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Research, 66, 6063–6071.
Lowther, W., Wiley, K., Smith, G. H., & Callahan, R. (2005). A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. Journal of Virology, 79, 10093–10096.
MacArthur, C. A., Shankar, D. B., & Shackleford, G. M. (1995). Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. Journal of Virology, 69, 2501–2507.
Mant, C., Hodgson, S., Hobday, R., D’Arrigo, C., & Cason, J. (2004). A viral aetiology for breast cancer: Time to re-examine the postulate. Intervirology, 47, 2–13.
Marchetti, A., Buttitta, F., Miyazaki, S., Gallahan, D., Smith, G. H., & Callahan, R. (1995). Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. Journal of Virology, 69, 1932–1938.
Marsh, S. K., Bansal, G. S., Zammit, C., Barnard, R., Coope, R., Roberts-Clarke, D., et al. (1999). Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene, 18, 1053–1060.
McCann, A. H., Miller, N., O’Meara, A., Pedersen, I., Keogh, K., Gorey, T., et al. (1996). Biallelic expression of the IGF2 gene in human breast disease. Human Molecular Genetics, 5, 1123–1127.
Medina, D. (1996). The mammary gland: A unique organ for the study of development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia, 1, 5–19.
Medina, D. (2000). The preneoplastic phenotype in murine mammary tumorigenesis. Journal of Mammary Gland Biology and Neoplasia, 5, 393–407.
Medina, D. (2008). Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens. Journal of Mammary Gland Biology and Neoplasia, 13, 271–277.
Mertz, J. A., Mustafa, F., Meyers, S., & Dudley, J. P. (2001). Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1. Journal of Virology, 75, 2174–2184.
Mertz, J. A., Simper, M. S., Lozano, M. M., Payne, S. M., & Dudley, J. P. (2005). Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus. Journal of Virology, 79, 14737–14747.
Mester, J., Wagenaar, E., Sluyser, M., & Nusse, R. (1987). Activation of int-1 and int-2 mammary oncogenes in hormone-dependent and -independent mammary tumors of GR mice. Journal of Virology, 61, 1073–1078.
Meurette, O., Stylianou, S., Rock, R., Collu, G. M., Gilmore, A. P., & Brennan, K. (2009). Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Research, 69, 5015–5022.
Michaelson, J. S., & Leder, P. (2001). beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene, 20, 5093–5099.
Michalides, R., Wagenaar, E., Hilkens, J., Hilgers, J., Groner, B., & Hynes, N. E. (1982a). Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice. Journal of Virology, 43, 819–829.
Michalides, R., Wagenaar, E., & Sluyser, M. (1982b). Mammary tumor virus DNA as a marker for genotypic variance within hormone-responsive GR mouse mammary tumors. Cancer Research, 42, 1154–1158.
Michalides, R., Wagenaar, E., & Weijers, P. (1985). Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure. Molecular and Cellular Biology, 5, 823–830.
Miele, L. (2006). Notch signaling. Clinical Cancer Research, 12, 1074–1079.
Mikkers, H., Allen, J., Knipscheer, P., Romeijn, L., Hart, A., Vink, E., et al. (2002). High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nature Genetics, 32, 153–159.
Mink, S., Ponta, H., & Cato, A. C. (1990). The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements. Nucleic Acids Research, 18, 2017–2024.
Mochizuki, S., & Okada, Y. (2007). ADAMs in cancer cell proliferation and progression. Cancer Science, 98, 621–628.
Moore, R., Dixon, M., Smith, R., Peters, G., & Dickson, C. (1987). Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: Two frameshift suppression events are required for translation of gag and pol. Journal of Virology, 61, 480–490.
Morris, D. W., Barry, P. A., Bradshaw, H. D., Jr., & Cardiff, R. D. (1990). Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain. Journal of Virology, 64, 1794–1802.
Muller, W. J., Lee, F. S., Dickson, C., Peters, G., Pattengale, P., & Leder, P. (1990). The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO Journal, 9, 907–913.
Mustafa, F., Bhadra, S., Johnston, D., Lozano, M., & Dudley, J. P. (2003). The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis. Journal of Virology, 77, 3866–3870.
Mustafa, F., Lozano, M., & Dudley, J. P. (2000). C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene. Journal of Virology, 74, 9431–9440.
Nam, J. S., Turcotte, T. J., Smith, P. F., Choi, S., & Yoon, J. K. (2006). Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression. Journal of Biological Chemistry, 281, 13247–13257.
Niehrs, C. (2006). Function and biological roles of the dickkopf family of Wnt modulators. Oncogene, 25, 7469–7481.
Nusse, R., de Moes, J., Hilkens, J., & van Nie, R. (1980). Localization of a gene for expression of mouse mammary tumor virus antigens in the GR/Mtv-2- mouse strain. Journal of Experimental Medicine, 152, 712–719.
Nusse, R., & Varmus, H. E. (1982). Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31, 99–109.
Paik, S. (1992). Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Research and Treatment, 22, 31–38.
Parks, W. P., Ransom, J. C., Young, H. A., & Scolnick, E. M. (1975). Mammary tumor virus induction by glucocorticoids. Characterization of specific transcriptional regulation. Journal of Biological Chemistry, 250, 3330–3336.
Peters, G., Brookes, S., Smith, R., & Dickson, C. (1983). Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for provirus integration in mammary tumors. Cell, 33, 369–377.
Peters, G., Brookes, S., Smith, R., Placzek, M., & Dickson, C. (1989). The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proceedings of the National Academy of Science of the USA, 86, 5678–5682.
Peters, G., Lee, A. E., & Dickson, C. (1984). Activation of cellular gene by mouse mammary tumour virus may occur early in mammary tumour development. Nature, 309, 273–275.
Powers, C. J., McLeskey, S. W., & Wellstein, A. (2000). Fibroblast growth factors, their receptors and signaling. Endocrine Related Cancer, 7, 165–197.
Qin, W., Golovkina, T. V., Peng, T., Nepomnaschy, I., Buggiano, V., Piazzon, I., et al. (1999). Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat. Journal of Virology, 73, 368–376.
Racevskis, J., & Beyer, H. (1989). Amplification of mouse mammary tumor virus genomes in non-mammary tumor cells. Journal of Virology, 63, 456–459.
Rajan, L., Broussard, D., Lozano, M., Lee, C. G., Kozak, C. A., & Dudley, J. P. (2000). The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas. Journal of Virology, 74, 2466–2471.
Reedijk, M., Odorcic, S., Chang, L., Zhang, H., Miller, N., McCready, D. R., et al. (2005). High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Research, 65, 8530–8537.
Reuss, F. U., & Coffin, J. M. (1998). Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene. Journal of virology, 72, 6073–6082.
Richert, M. M., Schwertfeger, K. L., Ryder, J. W., & Anderson, S. M. (2000). An atlas of mouse mammary gland development. Journal of Mammary Gland Biology and Neoplasia, 5, 227–241.
Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., & Nusse, R. (1987). The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell, 50, 649–657.
Ringold, G. M., Yamamoto, K. R., Tomkins, G. M., Bishop, M., & Varmus, H. E. (1975). Dexamethasone-mediated induction of mouse mammary tumor virus RNA: A system for studying glucocorticoid action. Cell, 6, 299–305.
Robbins, J., Blondel, B. J., Gallahan, D., & Callahan, R. (1992). Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells. Journal of Virology, 66, 2594–2599.
Roelink, H., Wagenaar, E., Lopes, dS., & Nusse, R. (1990). Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain. Proceedings of theNational Academy of Sciences of theUSA, 87, 4519–4523.
Ross, S. R. (2008). MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue. Journal of Mammary Gland Biology and Neoplasia, 13, 299–307.
Ross, S. R., Hsu, C. L. L., Choi, Y., Mok, E., & Dudley, J. P. (1990). Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic MICE. Molecular and Cellular Biology (November), 10, 5822–5829.
Ross, S. R., Schofield, J. J., Farr, C. J., & Bucan, M. (2002). Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus. Proceedings of the National Academy of Sciences of the USA, 99, 12386–12390.
Salmons, B., Erfle, V., Brem, G., & Gunzburg, W. H. (1990). naf, a trans-regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region. Journal of virology, 64, 6355–6359.
Scheidereit, C., Geisse, S., Westphal, H. M., & Beato, M. (1983). The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature, 304, 749–752.
Shackleford, G. M., MacArthur, C. A., Kwan, H. C., & Varmus, H. E. (1993). Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. Proceedings of the National Academy of Sciences of the USA, 90, 740–744.
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M. L., et al. (2006). Generation of a functional mammary gland from a single stem cell. Nature, 439, 84–88.
Shimizu, H., Julius, M. A., Giarre, M., Zheng, Z., Brown, A. M., & Kitajewski, J. (1997). Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth and Differentiation, 8, 1349–1358.
Sluyser, M., & van Nie, R. (1974). Estrogen receptor content and hormone-responsive growth of mouse mammary tumors. Cancer Research, 34, 3253–3257.
Smith, G. H. (1978). Evidence for a precursor-product relationship between intracytoplasmic a particles and mouse mammary tumour virus cores. Journal of General Virology, 41, 193–200.
Sonnenberg, A., van Balen, P., Hilgers, J., Schuuring, E., & Nusse, R. (1987). Oncogene expression during progression of mouse mammary tumor cells; activity of a proviral enhancer and the resulting expression of int-2 is influenced by the state of differentiation. EMBO Journal, 6, 121–125.
Squartini, F., & Bistocchi, M. (1977). Bioactivity of C3H and RIII mammary tumor viruses in virgin female BALB/c mice. Journal of National Cancer Institute, 58, 1845–1847.
Squartini, F., Rossi, G., & Paoletti, I. (1963). Characters of mammary tumours in BALB/c female mice foster-nursed by C3H and RIII mothers. Nature, 197, 505–506.
Stylianou, S., Clarke, R. B., & Brennan, K. (2006). Aberrant activation of notch signaling in human breast cancer. Cancer Research, 66, 1517–1525.
Takahashi, K., Mitsui, K., & Yamanaka, S. (2003). Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature, 423, 541–545.
Telesnitsky, A., & Goff, S. P. (1997). Reversed transcription and the generation of retroviral DNA. In J. M. Coffin, S. H. Hughes, & H. E. Varmus (Eds.), Retroviruses (pp. 121–160). Cold Spring Harbor Laboratory Press (NY), USA.
Theodorou, V., Boer, M., Weigelt, B., Jonkers, J., Van der Valk, M., & Hilkens, J. (2004). Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene, 23, 6047–6055.
Theodorou, V., Kimm, M., Boer, M., Wessels, L., Theelen, W., Jonkers, J., et al. (2007). MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nature of Genetics, 39, 759–769.
Touw, I. P., & Erkeland, S. J. (2007). Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia. Molecular Therapy, 15, 13–19.
Tsukamoto, A. S., Grosschedl, R., Guzman, R. C., Parslow, T., & Varmus, H. E. (1988). Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell, 55, 619–625.
Uren, A. G., Kool, J., Berns, A., & van Lohuizen, M. (2005). Retroviral insertional mutagenesis: Past, present and future. Oncogene, 24, 7656–7672.
Uren, A. G., Kool, J., Matentzoglu, K., de Ridder, J., Mattison, J., van Uitert, M., et al. (2008). Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell, 133, 727–741.
van Amerongen, R., Mikels, A., & Nusse, R. (2008). Alternative wnt signaling is initiated by distinct receptors. Science Signaling, 1, re9.
Van Der Valk, M. A. (1981). Tumor incidence of the inbred mouse strains in the Netherlands cancer institute. In J. Hilgers & M. Sluyser (Eds.), Mammary tumors in the mouse (pp. 45–115). Amsterdam: Elsevier.
Van Nie, R. (1981). Mammary tumorigenesis in the GR mouse strain. In M. Sluyser & J. Hilgers (Eds.), Mammary tumors in the mouse (pp. 202–266). Amsterdam: Elsevier/North-Holland Publishing.
van Nie, R., & Dux, A. (1971). Biological and morphological characteristics of mammary tumors in GR mice. Journal of National Cancer Institute, 46, 885–897.
van Nie, R., & Verstraeten, A. A. (1975). Studies of genetic transmission of mammary tumour virus by C3Hf mice. International Journal of Cancer, 16, 922–931.
van Nie, R., Verstraeten, A. A., & de Moes, J. (1977). Genetic transmission of mammary tumour virus by GR mice. International Journal of Cancer, 19, 383–390.
Varmus, H. E., Quintrell, N., Medeiros, E., Bishop, J. M., Nowinski, R. C., & Sarkar, N. H. (1973). Transcription of mouse mammary tumor virus genes in tissues from high and low tumor incidence mouse strains. Journal of Molecular Biology, 79, 663–679.
Veltmaat, J. M., Mailleux, A. A., Thiery, J. P., & Bellusci, S. (2003). Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation, 71, 1–17.
Vogt, V. M. (1997). Retroviral virions and genomes. In J. M. Coffin, S. H. Hughes and H. E. Varmus (Eds.), Retroviruses (pp. 27–69). Cold Spring Harbor Laboratory Press (NY), USA.
Wang, Y., Holland, J. F., Bleiweiss, I. J., Melana, S., Liu, X., Pelisson, I., et al. (1995). Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Research, 55, 5173–5179.
Wang-Johanning, F., Frost, A. R., Johanning, G. L., Khazaeli, M. B., LoBuglio, A. F., Shaw, D. R., et al. (2001). Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clinical Cancer Research, 7, 1553–1560.
Watson, C. J., & Khaled, W. T. (2008). Mammary development in the embryo and adult: A journey of morphogenesis and commitment. Development, 135, 995–1003.
Wei, Q., Yokota, C., Semenov, M., Doble, B., Woodgett, J., & He, X. (2007). R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling. Journal of Biological Chemistry, 282, 15903–15911.
Wellinger, R. J., Garcia, M., Vessaz, A., & Diggelmann, H. (1986). Exogenous mouse mammary tumor virus proviral DNA isolated from a kidney adenocarcinoma cell line contains alterations in the U3 region of the long terminal repeat. Journal of Virology, 60, 1–11.
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., et al. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269–271.
Wong, G. T., Gavin, B. J., & McMahon, A. P. (1994). Differential transformation of mammary epithelial cells by Wnt genes. Molecular and Cellular Biology, 14, 6278–6286.
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjoblom, T., Leary, R. J., et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science, 318, 1108–1113.
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science, 300, 1749–1751.
Yanagawa, S., Kakimi, K., Tanaka, H., Murakami, A., Nakagawa, Y., Kubo, Y., et al. (1993). Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas. Journal of Virology, 67, 112–118.
Yanagawa, S., Tanaka, H., & Ishimoto, A. (1991). Identification of a novel mammary cell line-specific enhancer element in the long terminal repeat of mouse mammary tumor virus, which interacts with its hormone-responsive element. Journal of Virology, 65, 526–531.
Yoshimura, N., Sano, H., Hashiramoto, A., Yamada, R., Nakajima, H., Kondo, M., et al. (1998). The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clinical Immunology and Immunopathology, 89, 28–34.
Zhu, Q., & Dudley, J. P. (2002). CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription. Journal of Virology, 76, 2168–2179.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Vendel-Zwaagstra, A., Hilkens, J. (2011). Gene Discovery by MMTV Mediated Insertional Mutagenesis. In: Dupuy, A., Largaespada, D. (eds) Insertional Mutagenesis Strategies in Cancer Genetics. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7656-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7656-7_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7655-0
Online ISBN: 978-1-4419-7656-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)